The Discounted Cash Flow (DCF) valuation of Neurocrine Biosciences Inc (NBIX) is 151.06 USD. With the latest stock price at 119.12 USD, the upside of Neurocrine Biosciences Inc based on DCF is 26.8%.
Based on the latest price of 119.12 USD and our DCF valuation, Neurocrine Biosciences Inc (NBIX) is a buy. buying NBIX stocks now will result in a potential gain of 26.8%.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 8.0% | 7.2% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 108.14 - 275.66 | 151.06 |
| Upside | -9.2% - 131.4% | 26.8% |